|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50917348
???header.onlineuser??? :
870
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"joohyuk"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-12 |
Sacituzumab govitecan in HR+HER2- metastatic breast cancer: the randomized phase 3 EVER-132-002 trial
|
Xu;Binghe;Wang;Shusen;Yan;Min;Sohn;Joohyuk;Li;Wei;Tang;Jinhai;Wang;Xiaojia;Wang;Ying;Im;Seock-Ah;Jiang;Dongdong;Valdez;Theresa;Dasgupta;Anandaroop;Zhang;Yiran;Yan;Yilin;Komatsubara;Kimberly, M.;Chung;Wei-Pang;Ma;Fei;Dai;Ming-Shen |
| 國立成功大學 |
2024-08-20 |
Understanding the Carbon Additive/Sulfide Solid Electrolyte Interface in Nickel-Rich Cathode Composites and Prioritizing the Corresponding Interplay between the Electrical and Ionic Conductive Networks to Enhance All-Solid-State-Battery Rate Capability
|
Saqib;Saleem, Kashif;Embleton;James, Tom;Choi;Hong, Jae;Won;Sung-Jae;Ali;Jahanzaib;Ko;Kyungmok;Choi;Sumyeong;Jo;Mina;Park;Sungwoo;Park;Joohyuk;Kaveevivitchai;Watchareeya;Son;Yoonkook;Lee;Woo-Jae;Oh;Pilgun |
| 國立成功大學 |
2024-06-1 |
Imlunestrant, an oral selective estrogen receptor degrader (SERD), in combination with human epidermal growth factor receptor 2 (HER2) directed therapy, with or without abemaciclib, in estrogen receptor (ER) positive, HER2 positive advanced breast cancer
|
Bhave;Manali, A.;Jhaveri;Komal, L.;Kaufman;Peter, A.;Aftimos;Georges, Philippe;Lombard;Margaret, Janine;Sideras;Kostandinos;Im;Seock-Ah;Ma;Cynthia, X.;Lee;Kuo-Ting;Kim;Sung-Bae;Li;Yujia;Yuen;Eunice;Estrem;Shawn, T.;Nguyen;Bastien;Bacchion;Francesca;Ismail-Khan;Roohi;Beeram;Muralidhar;Sohn;Joohyuk |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
